Recombinant protein · Agonist of Follicle-stimulating hormone receptor (FSHR) · developed by Organon and Co
Corifollitropin alfa is a long-acting recombinant follicle-stimulating hormone analogue given as a single subcutaneous injection.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT00702234 | N/A | Pregnancy | Completed | OGN |
| NCT00703014 | N/A | Pregnancy | Completed | OGN |
| NCT00702273 | N/A | In Vitro Fertilization | Completed | OGN |
| NCT00702520 | N/A | Pregnancy | Completed | OGN |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
In Vitro FertilizationNeonatesPregnancy
Updated Oct 25, 2026. Something wrong or missing? Report it on the OGN page.
See OGN's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
OGN catalysts and pipeline →